Session date: 
12/03/2015 - 12:30pm to 1:30pm

Learning objectives:

Attendees will be able to:

  1. Describe mechanisms leading to DAH in general and in ANCA-associated vasculitis specifically
  2. Describe acute management options for patients based on disease severity
  3. Chose the appropriate remission induction therapy for patients with DAH caused by AAV
  4. Explain the role of plasma-exchange in the management of DAH caused by AAV and name ongoing clinical trials
Presenter: 
Ulrich Specks, MD
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota